LENZ

LENZ THERAPEUTICS INC

• Seeking Alpha·04/01 10:26

  LENZ Therapeutics: Speculative But Strong Buy

• Simply Wall St·04/01 10:14

  President of LENZ Therapeutics Evert Schimmelpennink Buys 57% More Shares

• TipRanks·03/31 02:03

  LENZ Therapeutics Insiders Go on a Buying Spree, Signaling Big Confidence Ahead

• Reuters·03/30 12:48

  Lenz CFO Daniel Chevallard acquires 7,500 common shares for $64,275

• Reuters·03/30 12:48

  Lenz CEO Evert Schimmelpennink acquires $0.25 million in common shares

• Reuters·03/30 12:47

  Lenz Therapeutics director Jeffrey P. George buys 5,592 shares worth $0.05 million

• Simply Wall St·03/29 12:37

  Analysts Just Slashed Their LENZ Therapeutics, Inc. (NASDAQ:LENZ) EPS Numbers

• TipRanks·03/29 00:09

  Lenz Therapeutics Earnings Call: High Spend, Growing Traction

• Seeking Alpha·03/27 22:39

  LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade)

• Simply Wall St·03/27 10:24

  LENZ Therapeutics, Inc. (NASDAQ:LENZ) Analysts Are Cutting Their Estimates: Here's What You Need To Know

• Dow Jones·03/26 15:51

  LENZ Therapeutics Price Target Cut to $26.00/Share From $52.00 by Citigroup

• Dow Jones·03/26 15:51

  LENZ Therapeutics Is Maintained at Buy by Citigroup

• Benzinga·03/26 15:42

  Citigroup Maintains Buy on LENZ Therapeutics, Lowers Price Target to $26

• TipRanks·03/26 10:31

  Lenz Therapeutics price target lowered to $26 from $52 at Citi

• TipRanks·03/25 15:10

  Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), LENZ Therapeutics (LENZ) and Sarepta Therapeutics (SRPT)